Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Lisanne C VerbruggenYuehan WangSaro H ArmenianMatthew J EhrhardtHelena J H van der PalElvira C van DalenJorrit W van AsEdit BárdiKatja BaustClaire BergerElio CastagnolaKatie A DevineJudith GebauerJordan Gilleland MarchakAdam W GlaserAndreas H GrollGabrielle M HaeuslerJaap den HartoghRiccardo HauptLars HjorthMiho KatoTomáš KepákMaria M W Rianne KoopmanThorsten LangerMiho MaedaGisela MichelMonica MuracaPaul C NathanSelina R van den OeverVesna PavasovicSatomi SatoFiona S M SchulteLillian SungWim TissingAnne UyttebroeckRenée L MulderClaudia Elisabeth KuehniRoderick SkinnerMelissa M HudsonLeontien C M KremerPublished in: Pediatric blood & cancer (2020)
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.